These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1692659)

  • 1. [Therapeutic effectiveness and safety of prazosin in the symptomatic treatment of benign prostatic hypertrophy].
    Jiménez Cruz JF; Server Pastor G; Rioja Sanz C; Salinas Casado J; Vela Navarrete R; Virseda Chamorro M
    Actas Urol Esp; 1990; 14(1):31-5. PubMed ID: 1692659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an alpha 1-adrenergic blocker (prazosin HCl) on micturition disturbances associated with benign prostatic hypertrophy.
    Shimizu K; Nakai K; Imai K; Yamanaka H
    Urol Int; 1990; 45 Suppl 1():36-9. PubMed ID: 1690479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
    Yamaguchi O; Shiraiwa Y; Kobayashi M; Yokota T; Ohinata M; Aoki H; Tsuzuki T; Ohori M
    Urol Int; 1990; 45 Suppl 1():40-6. PubMed ID: 1690481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia.
    Lepor H; Knapp-Maloney G; Wozniak-Petrofsky J
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):392-7. PubMed ID: 2477339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prazosin on patients with symptoms of benign prostatic hypertrophy.
    Steven ID; Coffey GA; Graham NM; Wlodarczyk J; Curtis P
    Aust Fam Physician; 1993 Jul; 22(7):1260-4. PubMed ID: 7690542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies on the effectiveness of prazosin HCl (Minipress tablets) in the treatment of dysuria accompanying benign prostatic hyperplasia.
    Aoki H; Ohninata M; Tsuzuki T; Ohhori M; Shiraiwa Y; Yamaguchi O; Kobayashi M; Yokota T; Numazato S; Sakuma S
    Urol Int; 1990; 45 Suppl 1():18-25. PubMed ID: 1690476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of prazosin HCl in the treatment of urinary flow obstruction due to prostatic hypertrophy.
    Kondo A; Gotoh M; Saito M; Takita T; Kobayashi M; Otani T; Ito K
    Urol Int; 1990; 45 Suppl 1():4-17. PubMed ID: 1690480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prazosin HCl on the urethral pressure profile in patients with benign prostatic hyperplasia.
    Nakamura K; Kawashita E; Osumi Y; Usui T; Ishibe T
    Urol Int; 1990; 45 Suppl 1():30-5. PubMed ID: 1690478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of prazosin in conservative treatment of benign prostatic hypertrophy].
    Górecki R; Krzeski T; Wasik J; Borówka A
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):549-51. PubMed ID: 1282713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience: symptomatic management of BPH with terazosin.
    Dunzendorfer U
    Urology; 1988 Dec; 32(6 Suppl):27-31. PubMed ID: 2462302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Tsai YS; Lan SK; Ou JH; Tzai TS
    Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia].
    Esteban Fuertes M; Salinas Casado J; Virseda Chamorro M; Ramírez Fernández JC; Salomon Moh'd S; Luengo Alpuente S; Resel Estévez L
    Arch Esp Urol; 1997 Dec; 50(10):1057-66. PubMed ID: 9494194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.
    Chapple CR; Christmas TJ; Milroy EJ
    Urol Int; 1990; 45 Suppl 1():47-55. PubMed ID: 1690482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study.
    Dunzendorfer U
    Arzneimittelforschung; 1989 Oct; 39(10):1289-91. PubMed ID: 2482025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of prazosin in the treatment of benign hypertrophy of the prostate. A case-control study].
    Adriazola Semino M; García Cobo E; De la Calle Muñoz I; Tejeda Bañez E; Romero F
    Actas Urol Esp; 1993 Jul; 17(7):402-4. PubMed ID: 7690177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report.
    Palacio A; Hernández C; Marqués A; Prats J; Espinosa FJ
    Arch Esp Urol; 2004 May; 57(4):451-60. PubMed ID: 15270291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.